The Indian medical devices industry is witnessing a significant leadership transition. Specifically, Anish Bafna has decided to step down from his active executive role at Healthium Medtech. He will now transition into the position of non-executive chairman. Meanwhile, the company plans to find a new chief executive within the next month.
A Planned Succession at Healthium Medtech
Consequently, Bafna will actively help select and onboard his successor. This proactive approach ensures a seamless leadership transition for the medical devices giant. Previously, Bafna joined the company in 2018. At that time, Apax Partners had recently acquired the firm. Later, in 2024, KKR acquired the business for approximately ₹7,000 crore. This competitive bidding process also involved other major pharmaceutical players. Thus, the company has always attracted significant investor interest.
Financial Performance and Market Challenges
However, the company faces some notable headwinds in the domestic market. For instance, earnings weakened significantly over the past two fiscal years. The company reported a loss of ₹38 crore in FY25. This downturn occurred due to one-time costs from the KKR acquisition. Nevertheless, revenue grew steadily from ₹589 crore in FY19 to ₹870 crore in FY25. Additionally, the domestic surgical products market experienced a temporary slowdown. Therefore, pricing flexibility remains constrained by intense competition.
Product Expansion and Global Reach
Additionally, Bafna expanded the product portfolio through several strategic acquisitions. For example, the company acquired CareNow Medical in 2021. Subsequently, it purchased a controlling stake in Paramount Surgimed. Today, the manufacturer exports surgical consumables to over 90 countries. Furthermore, high entry barriers protect the medtech industry from quick disruption. These barriers include strong distribution networks and complex technical certifications. Professionals interested in the surgery speciality often find that understanding the device ecosystem is vital for clinical success.
Frequently Asked Questions
Q1: Who will replace Anish Bafna as the CEO of Healthium Medtech?
The company expects to appoint a new chief executive within the next month, and Bafna will assist in onboarding his successor.
Q2: Which global investment firm currently owns Healthium Medtech?
KKR acquired the medical devices firm in 2024 for approximately ₹7,000 crore following a competitive bidding process.
Q3: What products does the company manufacture?
The company manufactures a wide range of surgical and medical consumables, including surgical sutures, needles, meshes, and gloves.
References
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairmanrole – ETHealthworld
- Anish Bafna: CEO & Managing Director, Healthium Group – Top 100 Awards
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.